The lawsuit escalates an unusual, high-profile battle between two large pharmaceutical companies over ownership of a coveted developer of obesity drugs.

Pfizer has filed a lawsuit against Metsera and Novo Nordisk, saying Metsera breached its merger agreement obligations.

Novo Nordisk's late bid to hijack Pfizer's takeover of US obesity biotech Metsera marks an aggressive shift from the Danish drugmaker as it seeks to regain ground in the weight-loss drug market under ...

Pfizer has decided to sue Metsera and Novo over $8.5B bid, citing antitrust risks and asserting regulatory advantage.

Trump-Xi truce talks, Nvidia’s $5T milestone, Big Tech earnings, and Musk’s $1T showdown headline a packed week.

In a rapidly changing and uncertain world, Canada's new government is focused on what we can control. We are protecting our communities and our country. We are building our economy with major projects ...

The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly and fueling a bidding war over another drugmaker.

This data dropped around the same time as the beginning of a weight loss feud between Pfizer and Novo Nordisk after the ...

Nvidia ( NVDA) shares advanced on Wednesday to surpass a $5T market valuation, a level no publicly listed company has ...

While it may feel relaxing to put one’s mind on pause and endless scroll the feed of a favorite app, experts are urging ...

The moon will look slightly bigger and brighter Wednesday night during the closest supermoon of the year. The moon’s orbit around the Earth isn’t a perfect circle, so ...

Award recognizes the groundbreaking science of Dupixent and its transformational impact on multiple rare and common allergic and atopic conditions First and only therapy to specifically target the ...